Writer has released two new domain-specific AI models, Palmyra-Med 70B and Palmyra-Fin 70B, expanding the capabilities of NVIDIA NIM.
Overview
Writer has launched two domain-specific AI models, Palmyra-Med 70B and Palmyra-Fin 70B, enhancing NVIDIA NIM's capabilities in healthcare and finance. These models demonstrate superior accuracy compared to existing models like GPT-4 and Med-PaLM 2, making them ideal for specialized applications in regulated industries.
What You'll Learn
1
How to leverage Palmyra-Med 70B for clinical decision support
2
Why domain-specific LLMs outperform general-purpose models in regulated industries
3
How to utilize Palmyra-Fin 70B for financial trend analysis
Prerequisites & Requirements
- Understanding of generative AI and its applications in healthcare and finance(optional)
- Familiarity with NVIDIA NIM and TensorRT-LLM(optional)
Key Questions Answered
What are the performance benchmarks of Palmyra-Med 70B compared to other models?
Palmyra-Med 70B achieved an average score of 85.9% across various medical benchmarks, outperforming Med-PaLM 2 by nearly 2 percentage points. It also excelled in specific categories like MMLU Clinical Knowledge with a score of 90.9% and Medical Genetics with 94%.
How did Palmyra-Fin 70B perform on the CFA Level III exam?
Palmyra-Fin 70B scored 73% on the multiple-choice section of a CFA Level III sample test, making it the first model to pass this exam, whereas GPT-4 scored only 33%. This highlights the model's capability in financial analysis.
What improvements have been made to inference latency and token return rates?
NVIDIA's optimizations using TensorRT-LLM reduced inference latency by 23% for Palmyra-Med 70B and 30% for Palmyra-Fin 70B, while increasing the token return rate by approximately 60% for both models, enhancing responsiveness.
Key Statistics & Figures
Average score across medical benchmarks
85.9%
This score reflects Palmyra-Med 70B's performance compared to other models in medical applications.
CFA Level III exam score
73%
Palmyra-Fin 70B's score on the CFA Level III sample test demonstrates its proficiency in financial analysis.
Inference latency reduction
23% for Palmyra-Med 70B and 30% for Palmyra-Fin 70B
These reductions improve the responsiveness of the models during use.
Token return rate increase
~60%
This increase applies to both Palmyra-Med 70B and Palmyra-Fin 70B, enhancing user experience.
Technologies & Tools
Backend
Nvidia Nim
Platform for deploying the Palmyra models as microservices.
Backend
Nvidia Tensorrt-llm
Used for optimizing the performance of the Palmyra models.
Key Actionable Insights
1Utilize Palmyra-Med 70B to enhance clinical decision-making processes in healthcare applications.With its high accuracy in medical benchmarks, this model can significantly improve diagnostic accuracy and treatment planning, making it a valuable tool for healthcare professionals.
2Implement Palmyra-Fin 70B for advanced financial analysis and forecasting.This model's ability to analyze complex financial data and trends can aid financial institutions in making informed investment decisions and risk assessments.
3Leverage NVIDIA NIM microservices for deploying AI models efficiently.The availability of preconfigured containers allows for quick deployment across various platforms, enhancing the scalability and flexibility of AI applications.
Common Pitfalls
1
Overlooking the importance of domain-specific training data when utilizing LLMs.
Many developers may assume that general-purpose models will suffice for specialized applications, but this can lead to suboptimal performance in regulated industries like healthcare and finance.
Related Concepts
Generative AI Applications In Healthcare
Financial Modeling And Analysis
Regulatory Compliance In AI